Skip to main content
Peter Mahler, MD, Radiation Oncology, Madison, WI

PeterAMahlerMD

Radiation Oncology Madison, WI

Professor, Human Oncology, University of Wisconsin Medical School

Are you Dr. Mahler?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 25 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    3220 Tallyho LN
    Madison, WI 53705
    Phone+1 608-233-6732

Summary

  • Dr. Peter Mahler, MD is a radiation oncologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Illinois. He is affiliated with University Hospital and Fort HealthCare.

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 1987 - 1991
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1987
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Hospice and Palliative Medicine

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1988 - 2023
  • IL State Medical License
    IL State Medical License 1994 - 2020
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Press Mentions

  • New Coronavirus Strain Discovered in Ohio, Current Vaccines Believed Effective Against It
    New Coronavirus Strain Discovered in Ohio, Current Vaccines Believed Effective Against ItJanuary 13th, 2021
  • Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: The Single Most Important Factor in Determining the Future of SBRT Is Immune Response
    Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: The Single Most Important Factor in Determining the Future of SBRT Is Immune ResponseOctober 3rd, 2019